fbpx Skip to main content

Recall was announced out of an abundance of caution; no illnesses have been reported in connection with the formula

Another brand of baby formula is facing a recall. Formula manufacturer Reckitt recalled 145,000 cans of Enfamil ProSobee formula on Monday because of possible cross-contamination with Cronobacter sakazakii bacteria.

The safety issue “was linked to a material from a third party,” the company noted. All tests have been negative for the bacteria, but the recall was announced out of an abundance of caution. No illnesses have been reported in connection with the formula. The company said it has taken “all appropriate corrective actions, including no longer sourcing this material from the supplier.”

The recall is for 12.9-oz cans of formula manufactured between August and September 2022 with a use-by date of March 1, 2024. The cans have the codes ZL2HZF or ZL2HZZ on the bottom. Cans were shipped throughout the United States, Guam, and Puerto Rico. Customers should throw out these cans if they have them or return them to the stores where they were purchased for a refund. The recall does not affect any other ProSobee or Reckitt products.

Last year, four infants were sickened and two died in three states related to Cronobacter illness. Although all the infants had consumed powdered formula made by Abbott Inc. at its Michigan plant, genetic testing of Cronobacter found by the U.S. Food and Drug Administration at the plant did not match that related to the babies. Still, the Cronobacter found at the Abbott plant triggered a shutdown and a nationwide formula shortage.

More Information

You May Also Like::  Highlights From ASCO 2022 on Brentuximab Vedotin for CHL

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More